Miyake, Tomohiro, et al. “Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital.” SpringerPlus 2.1 (2013):273-273.

Wick, Catherine, et al. “Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.” American journal of health-system pharmacy 60.22 (2003):2314-2320.

Sessink, Paul J M, JasonTrahan, and Joseph WCoyne. “Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.” Hospital pharmacy 48.3 (2013):204-212.

Yoshida, Jin, et al. “Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.” Annals of occupational hygiene 53.2 (2009):153-160.

Favier, B, et al. “The PhaSeal system: impact of its use on workplace contamination and duration of chemotherapy preparation.” Journal of oncology pharmacy practice 18.1 (2012):37-45.

Harrison BR; Peters BG; Bing MR Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. American Journal of Health-System Pharmacy 2006 Sep 15; 63 (18): 1736-44.

Respiratory protective equipment: Cytotoxic Drugs. 2017

Gowns, Coveralls, and Overshoes: Cytotoxic Drugs. 2017

Sharma, Laveena [PhD (BiomedSc)]. Cytotoxic Drugs: Handling. 2017

Searched: PubMed, CINAHL, Joanna Briggs. Keywords: PhaSeal, Closed System Transfer device, safety

Updated links for entries from Joanna Briggs, 10/16/2017 ldt